Total Payments
$111,588
2024 Payments
$11,524
Companies
29
Transactions
319
Medicare Patients
7,661
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$75,153 (67.3%)
Other$20,071 (18.0%)
Food & Beverage$9,466 (8.5%)
Travel$6,841 (6.1%)
Gifts$56.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $75,153 | 31 | 67.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,072 | 11 | 18.0% |
| Food and Beverage | $9,466 | 241 | 8.5% |
| Travel and Lodging | $6,841 | 34 | 6.1% |
| Gift | $56.49 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $32,379 | 63 | $0 (2022) |
| Avadel Specialty Pharmaceuticals, LLC | $22,992 | 32 | $0 (2018) |
| Astellas Pharma US Inc | $13,242 | 17 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $8,763 | 26 | $0 (2024) |
| Boston Scientific Corporation | $7,721 | 17 | $0 (2023) |
| Verathon Inc. | $7,250 | 2 | $0 (2024) |
| Axonics, Inc. | $5,890 | 14 | $0 (2024) |
| UROVANT SCIENCES INC | $4,336 | 15 | $0 (2022) |
| BLUEWIND MEDICAL | $2,146 | 5 | $0 (2024) |
| Medtronic, Inc. | $2,049 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,524 | 43 | Sumitomo Pharma America, Inc. ($5,837) |
| 2023 | $15,603 | 56 | Boston Scientific Corporation ($7,570) |
| 2022 | $5,512 | 50 | UROVANT SCIENCES INC ($4,288) |
| 2021 | $7,797 | 45 | Axonics, Inc. ($5,735) |
| 2020 | $5,494 | 16 | Allergan, Inc. ($4,261) |
| 2019 | $5,277 | 15 | Allergan Inc. ($2,736) |
| 2018 | $45,418 | 63 | Avadel Specialty Pharmaceuticals, LLC ($22,992) |
| 2017 | $14,962 | 31 | Allergan Inc. ($8,554) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/06/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | Verathon Inc. | NPD Clinical Study (Device) | Consulting Fee | Cash or cash equivalent | $3,625.00 | General |
| Category: NPD Clinical Study | ||||||
| 09/18/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: UROLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: UROLOGY | ||||||
| 08/02/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: UROLOGY | ||||||
| 07/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $169.99 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 06/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: UROLOGY | ||||||
| 06/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Consulting Fee | Cash or cash equivalent | $2,820.00 | General |
| Category: UROLOGY | ||||||
| 06/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: UROLOGY | ||||||
| 06/17/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Urology | ||||||
| 06/10/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Urology | ||||||
| 05/23/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,964 | 35,541 | $1.5M | $337,613 |
| 2022 | 24 | 1,916 | 36,615 | $1.4M | $350,548 |
| 2021 | 23 | 2,033 | 33,500 | $1.4M | $350,252 |
| 2020 | 24 | 1,748 | 27,814 | $1.2M | $277,074 |
Total Patients
7,661
Total Services
133,470
Medicare Billing
$1.3M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 86 | 30,000 | $480,000 | $149,015 | 31.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 87 | 172 | $207,432 | $50,749 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 323 | $111,112 | $27,912 | 25.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 73 | 73 | $81,579 | $18,218 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 224 | 241 | $55,912 | $14,101 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $52,234 | $11,662 | 22.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 64 | $53,568 | $11,235 | 21.0% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 73 | 73 | $50,887 | $9,767 | 19.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 63 | $127,890 | $8,222 | 6.4% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 45 | 3,280 | $32,800 | $6,861 | 20.9% |
| 51726 | Complex measurement of pressure of urine flow in bladder | Office | 2023 | 28 | 28 | $34,418 | $5,713 | 16.6% |
| 51705 | Simple change of bladder tube | Office | 2023 | 45 | 77 | $34,496 | $5,164 | 15.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 48 | 71 | $33,228 | $4,619 | 13.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 97 | 97 | $67,745 | $2,100 | 3.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 211 | 235 | $18,800 | $1,824 | 9.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $7,634 | $1,750 | 22.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 385 | 511 | $9,198 | $1,732 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $7,424 | $1,703 | 22.9% |
| 51600 | Injection procedure for imaging of bladder during voiding | Office | 2023 | 14 | 14 | $11,900 | $1,236 | 10.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 22 | 26 | $8,034 | $1,201 | 15.0% |
| 51102 | Aspiration of bladder with insertion of bladder tube to skin | Facility | 2023 | 12 | 12 | $12,060 | $1,040 | 8.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 17 | $5,882 | $919.64 | 15.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $2,240 | $578.06 | 25.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 12 | $1,716 | $289.55 | 16.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 96 | 33,000 | $528,000 | $157,034 | 29.7% |
About Dr. Gary Lemack, MD
Dr. Gary Lemack, MD is a Urology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033179486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Lemack, MD has received a total of $111,588 in payments from pharmaceutical and medical device companies, with $11,524 received in 2024. These payments were reported across 319 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($75,153).
As a Medicare-enrolled provider, Lemack has provided services to 7,661 Medicare beneficiaries, totaling 133,470 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Dallas, TX
- Active Since 03/27/2006
- Last Updated 04/23/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1033179486
Products in Payments
- BOTOX (Biological) $29,307
- Noctiva (Drug) $22,992
- GEMTESA (Drug) $13,099
- NPD Clinical Study (Device) $7,250
- MIRABEGRON (Drug) $7,073
- Myrbetriq (Drug) $6,096
- Axonics r-SNM System (Device) $5,407
- BOTOX (Drug) $2,736
- INTERSTIM (Device) $2,730
- NOCDURNA (Drug) $1,963
- REVI (Device) $1,083
- RENOVA $1,050
- BOTOX OAB (Drug) $673.74
- Bulkamid (Device) $482.75
- GENTLECATH GLIDE (Device) $125.49
- Aimovig (Biological) $124.99
- Bard Urinary Drainage Bag (Device) $111.11
- SpeediCath (Device) $109.63
- BOTOX-UROLOGY (Drug) $109.37
- Caiman Vessel Sealers (Device) $104.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Dallas
Dr. Allen Morey, Md, MD
Urology — Payments: $948,145
Urology $948,145
Dr. Vitaly Margulis, Md, MD
Urology — Payments: $524,117
Urology $524,117
Yair Lotan, Md, MD
Urology — Payments: $356,810
Urology $356,810
Claus Roehrborn, Md, MD
Urology — Payments: $288,665
Urology $288,665
Samantha Nealon, M.d, M.D
Urology — Payments: $89,501
Urology $89,501
Brian Langford, M.d, M.D
Urology — Payments: $56,769
Urology $56,769